{"id":192821,"date":"2026-07-12T01:43:46","date_gmt":"2026-07-12T07:13:46","guid":{"rendered":"https:\/\/newslink360.space\/?p=192821"},"modified":"2026-07-12T01:43:46","modified_gmt":"2026-07-12T07:13:46","slug":"precision-medicine-shows-promise-in-advanced-gastric-cancer","status":"publish","type":"post","link":"https:\/\/newslink360.space\/?p=192821","title":{"rendered":"Precision Medicine Shows Promise In Advanced Gastric Cancer"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<p class=\"PDq2pG_selectionAnchorContainer\" data-start=\"758\" data-end=\"944\">PRECISION medicine is transforming first line treatment for advanced gastric cancer by prioritizing biomarker guided therapy selection and more personalized clinical decision making.<\/p>\n<h2 data-start=\"946\" data-end=\"990\">Precision Medicine Moves to the Forefront<\/h2>\n<p data-start=\"992\" data-end=\"1601\">Advanced <a href=\"https:\/\/www.emjreviews.com\/en-us\/amj\/oncology\/news\/fgfr2-amplified-gastric-cancer-responds-to-infigratinib\/\" target=\"_blank\" rel=\"noopener\">gastric cancer<\/a> remains associated with poor survival, particularly because many patients present with unresectable or metastatic disease. The newly published expert consensus highlights how precision medicine is replacing the historical one size fits all treatment approach by recommending routine biomarker testing before selecting first line therapy. The recommendations emphasize that identifying molecular characteristics can improve treatment selection while helping clinicians better match patients with therapies most likely to provide meaningful benefit.<\/p>\n<p data-start=\"1603\" data-end=\"1999\">The consensus outlines 27 evidence based recommendations covering biomarker assessment and treatment selection. Routine testing for mismatch repair status, microsatellite instability, HER2, PD L1, Claudin 18.2, Epstein Barr virus, and selected emerging biomarkers is recommended to guide individualized therapeutic strategies whenever clinically appropriate.<\/p>\n<h2 data-start=\"2001\" data-end=\"2048\">Biomarker Testing Drives Treatment Decisions<\/h2>\n<p data-start=\"2050\" data-end=\"2712\">The recommendations place particular emphasis on integrating biomarker testing into routine clinical practice before initiating treatment. Patients with MSI high or deficient mismatch repair tumors may derive substantial benefit from immune checkpoint inhibitor based therapy. HER2 expression continues to guide anti HER2 treatment, while PD L1 expression remains important for determining which patients are most likely to benefit from immunotherapy combinations. Claudin 18.2 expression is also identified as an increasingly important therapeutic target, particularly for patients whose tumors demonstrate high expression.<\/p>\n<p data-start=\"2714\" data-end=\"2994\">The document also recommends a more detailed four category classification of HER2 expression rather than the traditional positive or negative approach, reflecting the expanding role of targeted therapies in advanced gastric cancer management.<\/p>\n<h2 data-start=\"2996\" data-end=\"3046\">Building a More Personalized Treatment Strategy<\/h2>\n<p data-start=\"3048\" data-end=\"3829\">Beyond individual biomarkers, the consensus highlights the importance of evaluating combinations of molecular features when developing treatment plans. The authors note that gastric cancer demonstrates considerable biological heterogeneity, requiring treatment decisions that consider multiple biomarkers alongside clinical characteristics. Standardized testing, multidisciplinary collaboration, and continued refinement of precision medicine strategies are expected to improve consistency across clinical practice while expanding access to personalized care. Future advances in artificial intelligence, multimodal data analysis, and novel targeted therapies may further strengthen precision oncology for patients with advanced gastric cancer.<\/p>\n<p data-start=\"3836\" data-end=\"3849\"><strong>Reference<\/strong><\/p>\n<p data-start=\"3851\" data-end=\"3980\">Zhang X et al. <em data-start=\"3866\" data-end=\"3946\">Chinese consensus on first line precision therapy for advanced gastric cancer.<\/em> The Innovation. 2026;7(7):101305.<\/p>\n<p data-start=\"3982\" data-end=\"4042\"><em>Featured Image: Pormezz on Adobe Stock.<\/em><\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.emjreviews.com\/oncology\/news\/precision-medicine-reshapes-first-line-gastric-cancer-care\/\" target=\"_blank\" rel=\"noopener\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PRECISION medicine is transforming first line treatment for advanced gastric cancer by prioritizing biomarker guided therapy selection and more personalized clinical decision making. Precision Medicine Moves to the Forefront Advanced gastric cancer remains associated with poor survival, particularly because many patients present with unresectable or metastatic disease. The newly published expert consensus highlights how precision &#8230; <a title=\"Precision Medicine Shows Promise In Advanced Gastric Cancer\" class=\"read-more\" href=\"https:\/\/newslink360.space\/?p=192821\" aria-label=\"Read more about Precision Medicine Shows Promise In Advanced Gastric Cancer\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":192822,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-192821","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_236894546.jpeg","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":190167,"url":"https:\/\/newslink360.space\/?p=190167","url_meta":{"origin":192821,"position":0},"title":"Gastric Cancer Risk Score Validated","author":"Ajay Kumar Verma","date":"July 5, 2026","format":false,"excerpt":"RESEARCHERS have developed and validated an oesophageal and gastric cancer risk score using UK Biobank data, designed to identify adults aged over 50 at elevated risk of upper gastrointestinal cancer using only self-reported clinical and lifestyle information. Gastric Cancer Risk Score Researchers drew on 375,280 participants aged 50 years and\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Gastro-1pm.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Gastro-1pm.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Gastro-1pm.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Gastro-1pm.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":192831,"url":"https:\/\/newslink360.space\/?p=192831","url_meta":{"origin":192821,"position":1},"title":"Staging Preclinical Alzheimer&#8217;s Disease Pathologies","author":"Ajay Kumar Verma","date":"July 12, 2026","format":false,"excerpt":"COMBINED tau biomarkers track early cognitive decline and forecast structural neurodegeneration in preclinical Alzheimer\u2019s disease. Clinicians evaluating asymptomatic individuals with confirmed amyloid-beta deposition frequently face significant prognostic challenges due to variable disease trajectories. While plasma biomarkers offer high diagnostic sensitivity, they lack spatial precision regarding fibrillar protein localization in specific\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_732056927.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_732056927.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_732056927.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_732056927.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":185408,"url":"https:\/\/newslink360.space\/?p=185408","url_meta":{"origin":192821,"position":2},"title":"Radiation Therapy May Carry Sexual Health Risks \u2013 EMJ","author":"Ajay Kumar Verma","date":"June 25, 2026","format":false,"excerpt":"RADIATION THERAPY for gynecologic cancers carries lasting adverse effects on sexual health, a new systematic review has found.1 Patient-Reported Outcomes Researchers analysed a total of 26 studies, comprising data from 5,646 patients. In analysis, 11 studies focused on cervical cancer, seven on endometrial cancer, and eight on mixed gynecological malignancies.\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-repro-2.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":185518,"url":"https:\/\/newslink360.space\/?p=185518","url_meta":{"origin":192821,"position":3},"title":"Hidradenitis Suppurativa and ICIs &#8211; AMJ","author":"Ajay Kumar Verma","date":"June 25, 2026","format":false,"excerpt":"HIDRADENITIS suppurativa may newly develop or flare in some patients receiving immune checkpoint inhibitor therapy. Hidradenitis Suppurativa During Cancer Immunotherapy Immune checkpoint inhibitors have transformed cancer treatment, but their immune-mediated effects can extend beyond tumor control. A new scoping review suggests that hidradenitis suppurativa may emerge after immune checkpoint inhibitor\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":174807,"url":"https:\/\/newslink360.space\/?p=174807","url_meta":{"origin":192821,"position":4},"title":"New genomic test may help millions of breast cancer patients avoid chemotherapy &#8211; CNBC TV18","author":"Ajay Kumar Verma","date":"May 30, 2026","format":false,"excerpt":"New genomic test may help millions of breast cancer patients avoid chemotherapy\u00a0\u00a0CNBC TV18Millions of breast cancer patients could safely avoid chemotherapy, study suggests\u00a0\u00a0BBCGroundbreaking genomic test could spare millions of breast cancer patients chemotherapy\u00a0\u00a0The GuardianSkip the chemo: Millions of breast cancer patients could be spared chemotherapy with groundbreaking genomic test\u00a0\u00a0The Times\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/05\/J6_coFbogxhRI9iM864NL_liGXvsQp2AupsKei7z0cNNfDvGUmWUy20nuUhkREQyrpY4bEeIBucs0-w300-rw.webp?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":190664,"url":"https:\/\/newslink360.space\/?p=190664","url_meta":{"origin":192821,"position":5},"title":"Intelligent Psoriasis Research Trends &#8211; AMJ","author":"Ajay Kumar Verma","date":"July 6, 2026","format":false,"excerpt":"INTELLIGENT psoriasis research is accelerating precision diagnosis, personalized treatment, and long-term management across dermatology. Intelligent Psoriasis Research Enters a New Era A bibliometric analysis of intelligent psoriasis research from 2005 to 2025 highlights a growing focus on digital tools that could support diagnosis, treatment selection, and disease monitoring. The study\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_413147956.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_413147956.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_413147956.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_413147956.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnRh4-Oa1","_links":{"self":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/192821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=192821"}],"version-history":[{"count":0,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/192821\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/media\/192822"}],"wp:attachment":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=192821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=192821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=192821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}